SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS ALECTINIB, COBIMETINIB, SATRALIZUMAB, VISMODEGIB, RISDIPLAM, OBINUTUZUMAB, EMICIZUMAB, TRASTUZUMAB SUBCUTÁNEO, TRASTUZUMAB EMTANSINA
1 dostawca nagrodzony•27 pakietów udzielonych•28,35 mln € udzielono
Zamawiający: Servicio Murciano de Salud / Espinardo, Spain
Wartość udzielona
28,35 mln €
Wartość szacunkowa
28,35 mln €
Udzielono za 100% wartości szacunkowej
Data udzielenia
12 lut 2024
Zwycięzcy
1
Udzielone pakiety
27
Wartości udzielenia
Suma z ogłoszenia
28,35 mln €
Suma pakietów
55,47 mln €
Suma z ogłoszenia TED i wartości pakietów nie są dokładnie zgodne.
Zwycięzcy
RIBERA DEL LOIRA, 50, ESP
28,1 mln € Ta umowa
27 ogłoszeń o udzieleniu•61 udzielonych pakietów•65,58 mln € łącznie
Udzielone pakiety
| Pakiet | Tytuł | Zwycięzca | Wartość | Główny CPV |
|---|---|---|---|---|
| LOT-0025 | Nie podano | 15,6 mln € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0022 | Nie podano | 7,9 mln € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0015 | ROCHE FARMA SAU | 7,4 mln € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0016 | ROCHE FARMA SAU | 4,4 mln € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0026 | ROCHE FARMA SAU | 3,0 mln € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0023 | Nie podano | 2,7 mln € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0011 | ROCHE FARMA SAU | 2,5 mln € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0012 | ROCHE FARMA SAU | 1,6 mln € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0013 | ROCHE FARMA SAU | 1,4 mln € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0003 | ROCHE FARMA SAU | 1,3 mln € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0001 | ROCHE FARMA SAU | 980 241 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0008 | ROCHE FARMA SAU | 915 270 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0019 | Nie podano | 884 112 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0018 | ROCHE FARMA SAU | 833 464 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0010 | ROCHE FARMA SAU | 732 220 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0014 | ROCHE FARMA SAU | 624 371 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0005 | ROCHE FARMA SAU | 606 492 € | Other nervous system medicinal products (33661700) | |
| LOT-0006 | ROCHE FARMA SAU | 436 464 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0002 | ROCHE FARMA SAU | 331 782 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0007 | ROCHE FARMA SAU | 320 345 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0020 | Nie podano | 272 995 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0017 | ROCHE FARMA SAU | 259 000 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0004 | ROCHE FARMA SAU | 206 546 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0024 | Nie podano | 118 477 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0009 | ROCHE FARMA SAU | 91 527 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0021 | ROCHE FARMA SAU | 52 499 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0027 | ROCHE FARMA SAU | — | Antineoplastic and immunomodulating agents (33652000) |